Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Gastroenterology

Clinical Pharmacology

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Clinical Gastroenterology and Hepatology | Feb 15, 2022 Clinical Pharmacology

Guselkumab for the treatment of Crohn disease: Induction results from the phase 2 GALAXI-1 study

Gastroenterology | Feb 12, 2022 Clinical Pharmacology

Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)

Diabetes, Obesity and Metabolism | Feb 12, 2022 Clinical Pharmacology

Randomized placebo‐controlled trial of losartan for pediatric nonalcoholic fatty liver disease

Hepatology | Feb 11, 2022 Clinical Pharmacology

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

Alimentary Pharmacology and Therapeutics | Feb 11, 2022 Clinical Pharmacology

A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial

HPB | Feb 11, 2022 Clinical Pharmacology

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis

Hepatology | Feb 10, 2022 Clinical Pharmacology

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Gut | Feb 10, 2022 Clinical Pharmacology

Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma

New England Journal of Medicine | Feb 08, 2022 Clinical Pharmacology

Long-term evolution of estimated glomerular filtration rate in patients with antiviral treatment for hepatitis C virus infection

Clinical Gastroenterology and Hepatology | Feb 08, 2022 Clinical Pharmacology

« Prev 1 2 Next »

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Guselkumab for the treatment of Crohn disease: Induction results from the phase 2 GALAXI-1 study

Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)

Randomized placebo‐controlled trial of losartan for pediatric nonalcoholic fatty liver disease

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma

Long-term evolution of estimated glomerular filtration rate in patients with antiviral treatment for hepatitis C virus infection

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Guselkumab for the treatment of Crohn disease: Induction results from the phase 2 GALAXI-1 study

Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)

Randomized placebo‐controlled trial of losartan for pediatric nonalcoholic fatty liver disease

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma

Long-term evolution of estimated glomerular filtration rate in patients with antiviral treatment for hepatitis C virus infection

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic